最新ニュース Tempus AI (NASDAQ:TEM) 株価情報

TEMPUS AI INC

Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Ark Invest's Cathie Wood Says Belief In Bitcoin's $1.5 Million Price Target By 2030 Has Grown

Equities

News

Markets

ETFs

ARKG

ARKK

GTLB

IRDM

キャシー・ウッドの大きな火曜日の賭け：株価下落にもかかわらず、テンパスAIに$780万を投入

Cathie Wood's Wednesday Moves: Ark Pours $1.36 Million Into Tempus AI Shares Following Deep 6 AI Acquisition, Offloads Rocket Lab Stock

General

$BTC

COIN

HOOD

木曜日の昨日、キャシー・ウッドのArkインベストメントが、ロビンフッド・マーケッツ（NASDAQ:HOOD）、コインベース・グローバル（NASDAQ:COIN）、テンパスAI（NASDAQ:TEM）の株式を中心に積極的な買い取引があった。これらの取引は暗号資産関連株銘柄に影響を与え、不安定な市場でおこなわれた。

Arkはロビンフッドとコインベースを積極的に購入

Mid Cap

Movers

CRDO

DJTWW

ENVX

FIZZ

GLBE

GRND

KVYO

STAA

TGLS

先週、これらの中型株は最も優れた業績を発揮しました。あなたのポートフォリオには含まれていますか？

中小株式市場　今週注目の10銘柄

Tempus AI Inc

TEMCO

J.P. Morgan Exchange-Traded Fund Trust JPMorgan Climate Change Solutions ETF

PERSOL HLDG CO LTD ORD by Persol Holdings Co Ltd

Persol Holdings Co Ltd

Tradr 2X Long QBTS Daily ETF Tradr 2X Long TEM Daily ETF

Touchstone ETF Trust Touchstone Sands Capital Emerging Markets ex-China Growth ETF

American Battery Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $0.04 by 450 percent. This is a 26.32 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $979.98 thousand which missed the analyst consensus estimate of $33.52 million by 97.08 percent.

Earnings

Earnings Misses

ABAT

American Battery Tech Q3 EPS $(0.14) Misses $0.04 Estimate, Sales $979.98K Miss $33.52M Estimate

Barclays analyst Adam Seiden maintains Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) with a Overweight and raises the price target from $475 to $530.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Deere, Raises Price Target to $530

Capstone Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) shares jumped on Friday after the building products distributor <a href="https://www.benzinga.com/pressreleases/25/05/ac45465443/capstone-reaffirms-100m-revenue-target-for-2025-accelerates-m-a-strategy-with-flexible-growth-cap" target="_blank" rel="noreferrer noopener">reaffirmed its 2025 financial targets</a>.
The firm, a building products distribution company, also posted a stable first-quarter update.
Illinois-based Capstone remains on track to reach $100 million in revenue and $10 million in adjusted EBITDA by year-end. A mix of organic growth and acquisitions fuels the momentum.
Capstone is pursuing multiple deals at 4–6x EBITDA, with up to 45% of consideration in non-cash terms, aimed at maximizing earnings while minimizing dilution. CEO Matthew Lipman said the company is positioned to double in size, supported by favorable deal valuations and strong operational performance.
Also Read: <a href="https://www.benzinga.com/news/25/04/44709544/exclusive-capstone-eyes-100-million-goal-with-southeast-expansion-targets-1500-acquisition-opportunities" target="_blank" rel="noreferrer noopener">Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities</a>
Capstone secured a flexible equity line of credit to fund acquisitions, which it plans to use only for transactions immediately accretive to earnings.
The firm&#8217;s subsidiary, Instone, maintained margin targets and cost discipline, despite weather-related project delays in the Northeast and Midwest. Management expects a recovery in activity by Q3. Instone also expanded geographically and continued rolling out proprietary products like Toro and Pangea.
Capstone's acquisition strategy spans tuck-ins and new platforms, allowing it to scale quickly amid persistent housing demand.
Price Action: CAPS shares are trading higher by 82.53% at $3.03 premarket on Friday.
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45466937/us-targets-european-digital-rules-in-free-speech-campaign-defending-american-big-tech">US Slams Europe&#8217;s Digital Laws, Calls Them A Danger To Free Expression And American Big Tech</a></li>
</ul>
Image: Shutterstock

Guidance

BECN

CAPS

iShares Dow Jones US Homenstruction Index Fund

Capstone Takes Big Swing On Acquisitions, Shares Soar

Benchmark analyst Fawne Jiang maintains Alibaba Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) with a Buy and lowers the price target from $190 to $176.

BABA

Benchmark Maintains Buy on Alibaba Gr Hldgs, Lowers Price Target to $176

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) may be approaching a critical inflection point that could spark a wave of <a href="https://www.benzinga.com/markets/25/05/45384345/top-altcoins-of-the-week-altcoin-market-pops-as-eth-pi-and-pepe-post-double-digit-gains">strength across the altcoin</a> market, according to a prominent cryptocurrency analyst.
What Happened: In a <a href="https://www.youtube.com/watch?v=OeJrP3Rf9UA">podcast</a> published on May 14, analyst Kevin pointed to the convergence of technical signals and improving macroeconomic trends that support a bullish scenario. 
He explained that Bitcoin's resistance at $106,800 (1.272 Fibonacci extension level) now aligns with a notable decline in BTC dominance and falling USDT dominance. 
Historically, this combination has preceded major altcoin rallies.
"We're seeing macro clarity," Kevin noted, citing strong labour data, consistent GDP growth and easing inflation. 
He believes the recent correction in Bitcoin has likely ended, and a new bullish phase is unfolding.
On the altcoin front, Kevin highlighted the Total3 chart, representing the total crypto market cap excluding BTC and ETH, which recently defended the &#8220;golden pocket&#8221; Fibonacci zone. 
After consolidating through turbulence, altcoins have now broken above the key $871 billion resistance and are forming a bullish inverse head and shoulders pattern.
His earlier forecast around Bitcoin dominance also played out accurately. 
Two weeks ago, Kevin called for resistance at the 65.45% level, aligned with the 0.786 macro-Fibonacci level. 
Since then, dominance has retreated sharply, setting the stage for altcoins to gain traction.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45463966/tom-lee-predicts-bitcoin-will-hit-1-5-million-in-10-years-calls-it-a-swiss-army-knife-of-money">Tom Lee Predicts Bitcoin Will Hit $1.5 Million In 10 Years, Calls It A &#8216;Swiss Army Knife&#8217; Of Money</a>
What's Next: Kevin is cautiously optimistic. 
While momentum is building, evidenced by a recent 3-day MACD cross above zero, typically a bullish signal, he emphasizes the importance of a clean breakout above $106,800 before declaring a full green light.
"We're gaining strength at this level, not fading into it like before," he said. If BTC can break out, Kevin sees potential upside toward $116,000 and $122,000.
Turning to Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), Kevin sees striking similarities between the current market structure and past super cycles. 
He projects possible targets between $1.10 and $1.25, referencing Fibonacci levels that previously marked major tops for the meme coin.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45445674/bitcoin-eyes-108000-but-one-thing-stands-in-the-way">Bitcoin Eyes $108,000, But One Thing Stands In The Way</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Bitcoin's Dominance Hits Resistance: Is The ETH, XRP, DOGE Rally Coming?

Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) on Friday said it is teaming up with Cleveland Clinic and G42 to introduce an artificial intelligence-powered health platform, aiming to redefine <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45464770/oracle-cleveland-clinic-and-g42-announce-strategic-partnership-to-launch-ai-based-global-healthcar" rel="noreferrer noopener">healthcare outcomes and delivery systems</a>. This alliance merges clinical, cloud, and AI expertise to accelerate the transition toward data-driven care models.
The initiative will focus on building an AI-first digital infrastructure to improve global public health systems, starting in the United States and the United Arab Emirates, by harnessing Oracle&#8217;s suite of tools and both partners&#8217; clinical and AI strengths.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/contracts/25/05/45375787/oracle-partners-with-sequre-to-bolster-cybersecurity-for-governments-enterprises" rel="noreferrer noopener">Oracle Partners With seQure To Bolster Cybersecurity For Governments, Enterprises</a>
The platform will integrate Oracle Cloud Infrastructure, Oracle&#8217;s AI Data Platform, and Oracle Health technologies with Cleveland Clinic&#8217;s clinical leadership and G42&#8217;s national-scale AI capabilities.
The company said its goal is to build secure, adaptable, and cost-effective care frameworks that broaden access to advanced treatment, improve diagnostic accuracy, reduce healthcare spending, and offer real-time visibility into public health patterns.
The platform is equipped to process vast volumes of real-world health data and give clinicians decision-making support at the point of care. Through the initiative, the line between research and treatment will blur.
&#8220;Aging populations, rising costs, and the complexity of care demand a complete reinvention of how healthcare is provided,&#8221; said Oracle&#8217;s Executive Chairman and CTO Larry Ellison.
Tom Mihaljevic, Cleveland Clinic CEO, called the venture &#8220;a bold leap forward&#8221; in global care, while Peng Xiao, Group CEO at G42, emphasized the opportunity to build a &#8220;health intelligence fabric.&#8221;
While still governed by a non-binding agreement, the initiative underscores growing momentum in public-private cooperation to reshape healthcare delivery globally.
Price Action: ORCL shares are trading lower by 0.15% to $159.17 at last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45441791/nvidia-scores-big-as-trump-brokers-major-ai-export-pact-with-uae-and-us-tech-giants" target="_blank" rel="noreferrer noopener">Nvidia Scores Big As Trump Brokers Major AI Export Pact With UAE and US Tech Giants</a></li>
</ul>
Image via Shutterstock

Health Care

ORCL

Oracle, Cleveland Clinic, G42 Unite To Launch AI-Powered Healthcare Platform

Scotiabank analyst Allan Verkhovski maintains Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) with a Sector Perform and raises the price target from $75 to $85.

Scotiabank Maintains Sector Perform on Zoom Communications, Raises Price Target to $85

Top Win International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) announced Friday it will <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45463363/topwin-prepares-to-enter-digital-assets-market-with-sora-ventures-driving-bitcoin-treasury-across-" rel="noreferrer noopener">enter the digital asset market</a> through a strategic partnership with Sora Ventures. The Hong Kong-based company also plans to rebrand as &#8220;AsiaStrategy,&#8221; pending shareholder and regulatory approval.
With Asia emerging as a hub for Web3 innovation, TopWin aims to capitalize on the region&#8217;s momentum by adopting a Bitcoin-backed treasury strategy, leveraging Sora Ventures&#8217; expertise, Globe Newswire reports.
While continuing its luxury watch business, TopWin will expand into crypto investments and hold Bitcoin as an inflation hedge and long-term asset on its balance sheet. The company seeks to replicate the success of MicroStrategy-style treasury models in Asia.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45446885/mastercard-taps-into-100-million-crypto-users-with-moonpay-partnership" rel="noreferrer noopener">Mastercard Taps Into 100 Million Crypto Users With MoonPay Partnership</a>
Sora Ventures, founded by Jason Fang, has backed over 30 crypto firms and recently launched a $150 million fund to build Bitcoin treasuries for public companies. Fang will join TopWin&#8217;s board and serve as co-CEO alongside Tony Ngai.
The rebranding to AsiaStrategy reflects TopWin&#8217;s push to become a key player in the decentralized economy, as Asia&#8217;s evolving regulatory landscape and tech-savvy population drive digital finance adoption.
Price Action: TOPW shares are trading higher by 24.3% at $9.32 at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/mid-cap/25/05/45464126/weride-launches-robotaxi-trial-operations-in-abu-dhabi" target="_blank" rel="noreferrer noopener">WeRide Launches Robotaxi Trial Operations In Abu Dhabi</a></li>
</ul>
Image via Shutterstock

Asia

Tech

TOPW

Why Is Top Win Stock Soaring On Friday?

WIIM

SRXH

SRXH stock has given up its prior gain. SRX Health Solutions shares were trading higher after the company reported a year-over-year increase in Q1 financial results.

Uber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) CEO Dara Khosrowshahi pushed back against the idea of a single dominant player in the transportation sector, saying on April 25 that "there will not be a winner-take-all."&nbsp;
At Semafor&#8217;s <a href="https://www.youtube.com/watch?v=VCb5-UEKU7s">World Economy Summit</a>, Khosrowshahi said the trillion-dollar industry is large enough to support multiple companies, including Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
&nbsp;&#8220;You could argue that rideshare is going to finally beat personal car ownership in a world where you&#8217;ve got robots driving all over the place,&#8221; Khosrowshahi said during a conversation with Semafor Editor-in-Chief Ben Smith, suggesting that autonomous tech won&#8217;t crown a single winner.
Don't Miss:
<ul class="wp-block-list">
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Transportation is a trillion-plus-dollar industry, and Khosrowshahi believes there is ample room for various players to innovate and prosper within this massive sector.
<h2 class="wp-block-heading">Austin Becomes Ground Zero For The Robotaxi Wars</h2>
Uber is already gearing up for this transformation, partnering with Alphabet's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>, GOOGL)) Waymo unit to roll out autonomous ride-hailing services in Austin, Texas and Atlanta.
Early this year, Uber users in Austin can now be matched with Waymo&#8217;s all-electric, fully autonomous Jaguar I-PACE vehicles for select rides, according to a<a href="https://investor.uber.com/news-events/news/press-release-details/2024/Uber-and-Waymo-Expand-Partnership-to-Bring-Autonomous-Ride-Hailing-to-Austin-and-Atlanta/default.aspx"> joint statement</a>. The fleet is expected to scale into the hundreds.
Meanwhile, Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is preparing its own move. During<a href="https://www.youtube.com/watch?v=vs4cfyyMWhQ&amp;t=672s"> Tesla&#8217;s Q1 earnings call</a> on April 23, Elon Musk said, &#8220;The team and I are laser-focused on bringing robotaxi to Austin in June. Unsupervised autonomy will first be solved for the Model Y in Austin.&#8221;
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
The service will use Tesla&#8217;s Full Self-Driving software, which, while advanced, still requires occasional human takeover.
"It is delightful, but I have to take over every once in a while," Khosrowshahi said of Tesla's Full Self-Driving feature. "It is an absolutely great product. Again, the car is terrific,&#8221; he said, adding that he owns a Tesla himself.
Despite Khosrowshahi&#8217;s openness to collaboration—saying Uber would &#8220;love to work with&#8221; Tesla—<a href="https://www.benzinga.com/startups/25/02/43644403/elon-musk-you-cant-stop-the-advent-of-electric-cars-says-ev-success-is-as-inevitable-as-cars-replacing-horses">Musk</a> isn&#8217;t quite on the same wavelength. During the Q1 earnings call, he took a jab at Waymo&#8217;s higher production costs, saying the company&#8217;s robotaxis cost &#8220;way mo&#8217; money.&#8221;&nbsp;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Former Waymo CEO John Krafcik told <a href="https://www.businessinsider.com/elon-musk-waymo-diss-john-krafcik-robotaxi-wars-cybercab-2025-4">Business Insider</a>, &#8220;Tesla has never competed with Waymo — they&#8217;ve never sold a robotaxi ride to a public rider, but they&#8217;ve sold a lot of cars.&#8221;
Tesla&#8217;s robotaxi ambitions will go head-to-head with Uber and Waymo in Austin. Though Tesla has not yet offered paid robotaxi rides, the company is aggressively promoting its upcoming June launch.
Meanwhile, Uber&#8217;s broader momentum continues. The company&#8217;s stock is up nearly 40% year-to-date, approaching record highs. Analysts attribute this surge to Uber&#8217;s push into autonomous vehicles and expanded delivery offerings, according to <a href="https://www.investors.com/news/technology/uber-stock-q1-2025-preview-robotaxi-tariffs">Investor&#8217;s Business Daily</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

GOOG

TSLA

UBER

Uber CEO Dara Khosrowshahi Says He Isn't Worried About Tesla's Robotaxis – 'Transportation Is A Trillion-Plus-Dollar Industry'

Scotiabank analyst Jonathan Goldman maintains Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) with a Sector Outperform and raises the price target from C$144 to C$146.

TSX:STN

Scotiabank Maintains Sector Outperform on Stantec, Raises Price Target to C$146

Scotiabank analyst Robert Hope maintains Keyera (TSX:<a class="ticker" href="https://www.benzinga.com/stock/KEY#TSX">KEY</a>) with a Sector Outperform and raises the price target from C$50 to C$51.

TSX:KEY

Scotiabank Maintains Sector Outperform on Keyera, Raises Price Target to C$51

Wells Fargo analyst Joseph Quatrochi maintains Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Overweight and lowers the price target from $205 to $200.

AMAT

Wells Fargo Maintains Overweight on Applied Mat, Lowers Price Target to $200

Eightco Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCTO#NASDAQ">OCTO</a>) reported quarterly losses of $(0.84) per share. This is a 159.15 percent decrease over earnings of $1.42 per share from the same period last year. The company reported $9.91 million in sales this quarter. This is a 24.56 percent increase over sales of $7.96 million the same period last year.

OCTO

Eightco Holdings Q1 EPS $(0.84) Down From $1.42 YoY, Sales $9.91M Up From $7.96M YoY

Wells Fargo analyst Derek Archila maintains Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) with a Equal-Weight and raises the price target from $11 to $18.

SEPN

Wells Fargo Maintains Equal-Weight on Septerna, Raises Price Target to $18

Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCAP#NASDAQ">CCAP</a>) with a Equal-Weight and lowers the price target from $16 to $15.

CCAP

Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $15

Wells Fargo analyst Praneeth Satish maintains Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) with a Equal-Weight and raises the price target from $10 to $11.

CSIQ

Wells Fargo Maintains Equal-Weight on Canadian Solar, Raises Price Target to $11

Wells Fargo analyst Roger Read maintains LandBridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LB#NYSE">LB</a>) with a Overweight and raises the price target from $82 to $93.

Wells Fargo Maintains Overweight on LandBridge, Raises Price Target to $93

Benchmark analyst Mike Hickey maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $225 to $250.

TTWO

Benchmark Maintains Buy on Take-Two Interactive, Raises Price Target to $250

Polar Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>) reported quarterly losses of $(0.50) per share. This is a 41.18 percent increase over losses of $(0.85) per share from the same period last year. The company reported $1.72 million in sales this quarter. This is a 2.93 percent decrease over sales of $1.77 million the same period last year.

POLA

Polar Power Q1 EPS $(0.50) Up From $(0.85) YoY, Sales $1.72M Down From $1.77M YoY

Press Releases

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

Small Cap

Opinion

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

AI Healthcare Boom Gains Speed as Regulators and Innovators Align

Tempus Reports First Quarter 2025 Results

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies

Fintech

Tradr Launches First Leveraged ETF on Tempus AI

Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline

ADMA

AVAI

BCTX

GEHC

ONCY

POAI

QBTS

RXRX

SDGR

STRO

TDOC

TSX:BCT

TSX:ONC

TVGN

Agilent Technologies

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Illumina

IQVIA Hldgs

Medpace Hldgs

Mesa Laboratories

Mettler-Toledo International, Inc. Common Stock

Mettler-Toledo Intl

Niagen Bioscience

Repligen

Revvity

Sotera Health

Stevanato Group

Bio-Techne

Thermo Fisher Scientific Inc Common Stock

Thermo Fisher Scientific

10x Genomics

Waters

West Pharmaceutical Services, Inc. Common Stock

West Pharmaceutical Servs

Piper Sandler

Morgan Stanley

Needham

BTIG

B of A Securities

18日、キャッシー・ウッド氏率いるArkインベストが、テンパス AI （NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>）、アドバンス・マイクロ・デバイス（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>）、メタ(NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>）の大量の取引をした。
テンパス AI取引で大量の株を購入したのは、Ark インベストのARK ゲノミック・レボリューションETF（Genomic Revolution ETF)（BATS：<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>）とARKイノベーション ETF（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>）ファンドである。それぞれ2万8646株と14万2530株の株式を買い増した。これは、テンパス AIの売上ミスと利益予想を上回るEPSを記録した<a href="https://in.benzinga.com/news/earnings/25/02/43927560/tempus-ai-q4-earnings-revenue-miss-eps-beat-strong-guidance-shares-move-lower">最新の決算報告</a>の後に行われた。この日の株価終値は45.74ドル、8.28％の下落を見せた。買い付けた株式の総額は、約783万ドルに上る。Arkインベストによるこの投資は、前回の<a href="https://www.benzinga.com/25/03/44293571/cathie-woods-wednesday-moves-ark-pours-1-36-million-into-tempus-ai-shares-following-deep-6-ai-acquisition-offload">133万6000ドルの購入</a>に続くもので、テンパス AIに対する同社の自信を物語っている。
アドバンス・マイクロ・デバイス取引では、ARKKファンドが3万324株を購入、株価終値は103.51ドル、約314万ドルの取引額であった。これは、AIとGPU市場における<a href="https://www.benzinga.com/25/03/44274365/amd-ceo-lisa-su-says-ai-boom-is-just-getting-started-and-amds-ready-to-cash-in">競争力を強めている</a>という最近のアナリストの視点に一致している。また、同社はAIの進歩と戦略的パートナーシップにより、2025年には20%以上の成長が見込まれている。
メタ取引では、ArkインベストのARKKファンドが、マーク・ザッカーバグ氏率いる同社の2160株を売却した。株価終値は1株あたり582.36ドル、売却額は約126万ドルである。これは、メタがビジネスメッセージングサービスから300〜400億ドルの収益を生み出す可能性があるという<a href="https://www.benzinga.com/markets/25/03/44374847/meta-could-rake-in-30-40-billion-in-revenue-from-whatsapp-business-messaging-predicts-analyst">アナリスト予測</a>の後の動きであり、市場がメタを過小評価を示している可能性がある。
なお、グローバル展開の取り組みやプライバシー慣行が厳しい監視の目にさらされているという報道が流れる中、月曜にはメタの株式について、Arkインベストが７百万ドル以上の株式を売却したことは注目である。
その他の主要取引：
<ul>
<li>ユーアイパス（PATH）：ARKKが482,454株、ARKFが27,345株を売却。</li>
<li>イルミナ（ILMN）：ARKKが86,375株、ARKGが17,469株を売却。</li>
<li>ギットラブ（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>）：ARKKが104,699株、ARKWが8,748株を購入。</li>
<li>イリジウム・コミュニケーションズ（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>）：ARKKが99,784株、ARKQが10,022株、ARKXが6,585株を購入。</li>
</ul>
＜出典：Shutterstock＞

木曜日の昨日、キャシー・ウッドのArkインベストメントが、ロビンフッド・マーケッツ（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>）、コインベース・グローバル（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>）、テンパスAI（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>）を中心とした積極的な買い取引をした。これらの取引は暗号資産関連株銘柄に影響を与え、不安定な市場でおこなわれた。
ロビンフッド取引では、ARKイノベーションETF（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>）が、ロビンフッドの14万3,855株を取得した。同社の株は1株36.02ドルで取引を終え、総額518万ドルでの投資となった。これは、最近の市場動向に一致した動きである。ほかの暗号資産関連銘柄と同様、ロビンフッドはビットコイン（暗号資産:<a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>）が8万ドルを割るという動きによって影響を受けた。それでもトレーダーは、市場における潜在的なチャンスを模索していると報じられている。
コインベース取引では、ARKKファンドがコインベースの2万9,353株を取得した。終値は1株177.49ドル、投資総額は521万ドル前後となった。コインベースはS&amp;P500に組み入れられていないことや暗号資産市場全体が低迷していることから、監視の目が向けられている。だが、ローゼンブラット(Rosenblatt)のクリス・ブレンドラー(Chris Brendler）氏のようなアナリストは、最近の調整が買いのチャンスであるとした前向きな見方を維持している。
テンパス AI取引では、ARKKファンドがテンパスAI の3万0119株を購入した。終値は1株42.16ドル、投資総額は約123万ドルだった。今回の取引は、水曜日の<a href="https://www.benzinga.com/25/03/44293571/cathie-woods-wednesday-moves-ark-pours-1-36-million-into-tempus-ai-shares-following-deep-6-ai-acquisition-offloads-rocket-lab-stock">前回の購入（136万ドル）</a>に続くものである。注目すべきは、今週は連日、Arkがテンパス AIの株を購入していることだ。月曜日のハイテク株暴落の中で、Arkは1,323万相当の株式を購入している。
<ul>
<li>ARKWはイボッタ（IBTA）の1万9,818株を購入、ARKFファンドは1万6,332株を購入。</li>
<li>ARKGファンドはクリスパー・セラピューティクス AG（CRSP）の1万7,742株を購入、ARKKファンドは8万8,232株を購入。</li>
<li>ARKKファンドはユーアイパス（PATH）の967,513株を売却、ARKWファンドは1万3,703株を売却。　　　　　　　　以上</li>
</ul>

先週、これらの中型株は最も優れた業績を発揮しました。あなたのポートフォリオには含まれていますか？
<ol>
<li>米国株式市場（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>）の株価は、同社のTempus ECG-AFデバイスが米国食品医薬品局（FDA）の510（k）の認可を取得したと発表したことを受けて30.43％上昇しました。このデバイスは、心房細動/フラッターのリスクが高いと考えられる患者を特定するのにAIが用いられています。</li>
<li>米国株式市場（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>）の株価は、アジアの大手家電バッテリーパックメーカーであるElentecがEnovix Corporationと覚書（MOU）に調印したことを発表した後、29.70％上昇しました。</li>
<li>Grindr Inc. （NYSE：<a class="ticker" href="https://www.benzinga.com/stock/GRND#NYSE">GRND</a>）の株式は、同社が<a href="https://www.benzinga.com//node/39504431" target="_blank" rel="noreferrer noopener">初の投資家向け説明会</a>を先取りして、今年の収益見通しを引き上げたことを受けて27.50％急伸しました。</li>
<li>Trump Media &amp; Technology Group Corp. （NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/DJTWW#NASDAQ">DJTWW</a>）の株式ワラントは、同社が2024年6月20日と21日に<a href="https://www.benzinga.com//node/39453772" target="_blank" rel="noreferrer noopener">現金による権利行使によって6940万ドル以上を受領することを期待している</a>と発表した後、18.33％上昇しました。</li>
<li>Credo Technology Group（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>）の株価は、TD Cowenが同社の株をBuyに格上げし、<a href="https://www.benzinga.com/quote/CRDO/analyst-ratings" target="_blank" rel="noreferrer noopener">株価目標を24ドルから35ドルに引き上げたことを受けて18.30％急騰しました</a>。</li>
<li>Tecnoglass Inc.（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/TGLS#NYSE">TGLS</a>）の株価は、同社が取締役会で戦略的な選択肢を検討していることを発表した後、17.90％上昇しました。また、同社は<a href="https://www.benzinga.com//node/39489521" target="_blank" rel="noreferrer noopener">2024年のFY24業績見通しを再確認しました</a>。</li>
<li>STAAR Surgical Company（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>）の株価は、16.55％上昇しています。</li>
<li>RXO Inc.（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/EXO#NYSE">EXO</a>）の株価は、先週、UPSから<a href="https://www.benzinga.com//node/39453065" target="_blank" rel="noreferrer noopener">Coyote Logisticsが買収されると発表されたことを受けて16.22%上昇しました。</a></li>
<li>Global-E Online Ltd（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>）の株価は先週、16.21%上昇しました。</li>
<li>SentinelOne Inc（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>）の株価は、DA Davidsonが同社の株に対するNeutral投資評価を維持し、株価予測を17ドルから18.5ドルに引き上げたことを受けて15.47%上昇しました。</li>
</ol>

新しい週の始まりに伴い、新しい一連の企業が公開を通じて影響を与えようとしているという興奮が高まっています。Benzinga Proによると、これらの魅力的な企業は今週公開取引を行う予定です。
<ul>
<li>Tempus AI（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>）は2024年6月14日に公開上場を開始します。同社は35.00ドルから37.00ドルの間で設定された価格帯を保有しており、180日間のロックアップ期間が設定されています。 Tempus AIは、1株36.00ドルで11,100,000株の株式を提供します。</li>
</ul>
<h3>IPOの評価</h3>
IPOとは、非公開企業が上場してその株式を証券取引所に投資家に対して提供するという過渡的なプロセスを指します。一般的に、IPOは企業が資本を構築することができる手段を提供します。企業が公開上場する前には、SECの要件を満たし、IPOの前に株式の価格、提供日、その他の重要なデータポイントを決定するための監査を受ける必要があります。
企業と投資銀行は、株式が売れることを期待される価格帯を確立するために作業を行います。これは提供範囲として知られています。企業が公開上場すると、株式にはオープニングプライスが付きます。インサイダーのロックアップ期間とは、IPO後の設定された日数の間に、企業関係者、または自社の10％以上の利益を持つ従業員が株式を売却できないというものです。

Comments

Tempus AI

ニュース

最新ニュース Tempus AI (NASDAQ:TEM) 株価情報

水曜日, 3 19, 2025

金曜日, 3 14, 2025

月曜日, 7 01, 2024

月曜日, 6 10, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル